159 related articles for article (PubMed ID: 7790095)
1. Protection against local Shigella sonnei infection in mice by parenteral immunization with a nucleoprotein subcellular vaccine.
Levenson VJ; Mallett CP; Hale TL
Infect Immun; 1995 Jul; 63(7):2762-5. PubMed ID: 7790095
[TBL] [Abstract][Full Text] [Related]
2. Protective ribosomal preparation from Shigella sonnei as a parenteral candidate vaccine.
Levenson VI; Egorova TP; Belkin ZP; Fedosova VG; Subbotina JL; Rukhadze EZ; Dzhikidze EK; Stassilevich ZK
Infect Immun; 1991 Oct; 59(10):3610-8. PubMed ID: 1716612
[TBL] [Abstract][Full Text] [Related]
3. Effective stimulation of the mucosal immune response by parenteral vaccination with weak antigen associated with a nucleoprotein vehicle.
Levenson VJ; Egorova TP
Ann N Y Acad Sci; 1994 Aug; 730():353-5. PubMed ID: 8080208
[No Abstract] [Full Text] [Related]
4. [Ribosomal dysentery vaccine. IV. Study of the reactogenicity, antigenic and protective activity of Shigella sonnei ribosomes in monkey experiments].
Dzhikidze EK; Kavtaradze KN; Levenson VI; Subbotina IuL; Fedosova VG
Zh Mikrobiol Epidemiol Immunobiol; 1981 Jul; (7):53-9. PubMed ID: 7025529
[No Abstract] [Full Text] [Related]
5. [Local immunity in the parenteral immunization of guinea pigs with a ribosomal dysentery vaccine].
Liubinskaia MM; Rukhadze EZ; Chernokhvostova EV; Levenson VI
Zh Mikrobiol Epidemiol Immunobiol; 1985 Jul; (7):55-9. PubMed ID: 3901625
[TBL] [Abstract][Full Text] [Related]
6. [Specificity of the protective action of a ribosomal Shigella vaccine and the absence of activity in the ribosomes from R mutants].
Levenson VI; Rukhadze EZ; Belkin ZP; Essaulova ME
Zh Mikrobiol Epidemiol Immunobiol; 1988 Oct; (10):55-9. PubMed ID: 2464261
[TBL] [Abstract][Full Text] [Related]
7. [Biological properties of a ribosomal vaccine from S. sonnei obtained by polyethylene glycol fractionation].
Levenson VI; Rukhadze EZ; Fedosova VG; Dzhikidze EK; Stasilevich ZK
Zh Mikrobiol Epidemiol Immunobiol; 1984 Nov; (11):77-81. PubMed ID: 6395593
[TBL] [Abstract][Full Text] [Related]
8. [Ribosomal dysentery vaccine. Study of response and antigenic activity in healthy volunteers].
Gavrilov AF; Gracheva NM; Fedosova VG; Rukhadze EZ; Levenson VI
Zh Mikrobiol Epidemiol Immunobiol; 1985 Sep; (9):12-5. PubMed ID: 3907215
[TBL] [Abstract][Full Text] [Related]
9. [Stimulation of the secretory IgA system in monkeys by parenteral immunization with a ribosomal Sonne dysentery vaccine].
Dzhikidze EK; Stasilevich ZK; Salamatova SA
Zh Mikrobiol Epidemiol Immunobiol; 1988 Sep; (9):66-70. PubMed ID: 2462772
[TBL] [Abstract][Full Text] [Related]
10. [Ribosomal dysentery vaccine. II. Biological trials of active protection for guinea pigs and mice].
Levinson VI; Subbotina IuL
Zh Mikrobiol Epidemiol Immunobiol; 1978 Jul; (7):81-6. PubMed ID: 358702
[TBL] [Abstract][Full Text] [Related]
11. Stable expression of Shigella sonnei form I O-polysaccharide genes recombineered into the chromosome of live Salmonella oral vaccine vector Ty21a.
Dharmasena MN; Hanisch BW; Wai TT; Kopecko DJ
Int J Med Microbiol; 2013 Apr; 303(3):105-13. PubMed ID: 23474241
[TBL] [Abstract][Full Text] [Related]
12. Prevention of shigellosis by a Salmonella typhi-Shigella sonnei bivalent vaccine.
Black RE; Levine MM; Clements ML; Losonsky G; Herrington D; Berman S; Formal SB
J Infect Dis; 1987 Jun; 155(6):1260-5. PubMed ID: 2437220
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and efficacy of oral or intranasal Shigella flexneri 2a and Shigella sonnei proteosome-lipopolysaccharide vaccines in animal models.
Orr N; Robin G; Cohen D; Arnon R; Lowell GH
Infect Immun; 1993 Jun; 61(6):2390-5. PubMed ID: 8500877
[TBL] [Abstract][Full Text] [Related]
14. Studies on acquired systemic resistance in mice with oral immunization with Shigella sonnei.
Kowalewska D; Wieczorek Z
Arch Immunol Ther Exp (Warsz); 1980; 28(2):345-55. PubMed ID: 7004395
[TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of IgG class and subclass and IgA serum response to Shigella sonnei and Shigella flexneri 2a polysaccharides following vaccination with Shigella conjugate vaccines.
Robin G; Keisari Y; Slepon R; Ashkenazi S; Cohen D
Vaccine; 1999 Aug; 17(23-24):3109-15. PubMed ID: 10462247
[TBL] [Abstract][Full Text] [Related]
16. Studies in volunteers to evaluate candidate Shigella vaccines: further experience with a bivalent Salmonella typhi-Shigella sonnei vaccine and protection conferred by previous Shigella sonnei disease.
Herrington DA; Van de Verg L; Formal SB; Hale TL; Tall BD; Cryz SJ; Tramont EC; Levine MM
Vaccine; 1990 Aug; 8(4):353-7. PubMed ID: 2204243
[TBL] [Abstract][Full Text] [Related]
17. Development of a Live Attenuated Bivalent Oral Vaccine Against Shigella sonnei Shigellosis and Typhoid Fever.
Wu Y; Chakravarty S; Li M; Wai TT; Hoffman SL; Sim BK
J Infect Dis; 2017 Jan; 215(2):259-268. PubMed ID: 27803169
[TBL] [Abstract][Full Text] [Related]
18. Shigella Sonnei vaccine.
Drugs R D; 1999 Sep; 2(3):222-3. PubMed ID: 10641235
[No Abstract] [Full Text] [Related]
19. Intransal or intragastric immunization with proteosome-Shigella lipopolysaccharide vaccines protects against lethal pneumonia in a murine model of Shigella infection.
Mallett CP; Hale TL; Kaminski RW; Larsen T; Orr N; Cohen D; Lowell GH
Infect Immun; 1995 Jun; 63(6):2382-6. PubMed ID: 7768627
[TBL] [Abstract][Full Text] [Related]
20. Specific immunoglobulin A-secreting cells in peripheral blood of humans following oral immunization with a bivalent Salmonella typhi-Shigella sonnei vaccine or infection by pathogenic S. sonnei.
Van de Verg L; Herrington DA; Murphy JR; Wasserman SS; Formal SB; Levine MM
Infect Immun; 1990 Jun; 58(6):2002-4. PubMed ID: 1692813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
